Substituted piperidines as BTK inhibitors
US11542266B1 · kind B1 · utility
0Cited by
0References
19Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 6, 2021 |
| Grant date | Jan 3, 2023 |
| Priority date | — |
| Expiry date | Oct 6, 2041 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07B2200/09
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Substituted piperidines as BTK inhibitors, a preparation method thereof and a pharmaceutical application thereof. The substituted piperidines is a compound represented by a general formula (I) or a stereoisomer or a pharmaceutically acceptable salt thereof, and the substituted piperidines is used to treat BTK-related diseases such as tumors or autoimmune system diseases. B-L-K formula (I)
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.